A New York family will go to court Wednesday to challenge the federal government, arguing that cannabis shouldn't be a Schedule 1 drug. Amanda Ostrowitz, co-founder and CEO of CannaRegs, says the case might not change the laws For full interview [click here](https://cheddar.com/videos/how-cannaregs-is-capitalizing-on-cannabis).

Share:
More In Business
Cava: Q2 Earnings Snapshot
Cava Group Inc. (CAVA) on Tuesday reported second-quarter profit of $6.5 million, beating Wall Street's expectations.
Load More